Last edition
News about "US Patent "
BioViva Secures US Patent for hTERT and Follistatin-344 Combination Therapy
BioViva has received a US patent covering therapeutic methods that combine hTERT and Follistatin-344, expanding its intellectual-property portfolio focused on genetic approaches to aging.
US Patent | 15/09/2026 | By News Bureau
FibroBiologics Secures US Patent for Fibroblast-Based Wound Healing Therapy
FibroBiologics receives a US patent covering topical fibroblast-based therapies designed to accelerate healing of chronic, diabetic and other difficult-to-heal wounds.
US Patent | 05/09/2026 | By News Bureau
XYRA receives a US patent protecting dose-adjusted budiodarone therapy for atrial fibrillation, aiming to reduce stroke and heart failure risk through patient monitoring while offering a safer rhythm-control option.
US Patent | 06/03/2026 | By News Bureau | 233
Jaya Biosciences Receives US Patent for Novel Methods of Treating Neurological Diseases
US patent grant to Jaya Biosciences broadens protection and strengthens the company’s leadership in developing CNS-directed therapies for genetically defined neurodegenerative diseases.
US Patent | 07/11/2025 | By Dineshwori | 388
Saghmos Gets US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator
Saghmos Therapeutics, Inc. has announced that the US Patent and Trademark Office (USPTO) has granted US Patent No. 11,986,473 titled, 'Prevention and/or Treatment of Contrast-Induced Acute Kidney Injury' for its Phase 3-ready product, ST-62516.
US Patent | 06/06/2024 | By Aishwarya | 657
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy